Institutional members access full text with Ovid®

Share this article on:

BLOOD PRESSURE TREATMENT WITH CANDESARTAN IN ACUTE STROKE:THE SCANDINAVIAN CANDESARTAN ACUTE STROKE TRIAL: LB1.6

Sandset, E. C.1; Bath, P. M. W.2; Boysen, G.3; Jatuzis, D.4; Kõrv, J.5; Lüders, S.6; Murray, G. D.7; Richter, P. S.8; Roine, R. O.9; Terent, A.10; Thijs, V.11; Berge, E.1On Behalf of The SCAST Study Group

Journal of Hypertension: June 2011 - Volume 29 - Issue - p e18
Saturday Orals: Late-Breaker Session: Late-Breaker Session 1

1 Department of Internal Medicine, Oslo University Hospital, Oslo-Norway, 2Stroke Trials Unit, Division of Stroke, University of Nottingham, City Hospital campus, Nottingham-United Kingdom, 3Department of Neurology, Bispebjerg Hospital and University of Copenhagen, Copenhagen-Denmark, 4Faculty of Medicine and Department of Neurology, Vilnius University Santariskiu Klinikos Hospital, Vilnius-Lithuania, 5Department of Neurology, Tartu University Hospital, Tartu-Estonia, 6Department of Internal Medicine, St Josefs Hospital, Cloppenburg-Germany, 7Centre for Population Health Sciences, University of Edinburgh, Edinburgh-United Kingdom, 8Department of Neurology, Institute of Psychiatry and Neurology, Warsaw-Poland, 9Department of Neurology, Turku University Hospital, Turku-Finland, 10Department of Medical Sciences, Uppsala University, Uppsala-Sweden, 11Department of Neurology, University Hospital Leuven, and Vesalius Research Center, VIB, Leuven-Belgium

© 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins